Smac mimetic LCL161 supports neuroblastoma chemotherapy in a drug class-dependent manner and synergistically interacts with ALK inhibitor TAE684 in cells with ALK mutation F1174L.
about
Smac mimetic LCL161 supports neuroblastoma chemotherapy in a drug class-dependent manner and synergistically interacts with ALK inhibitor TAE684 in cells with ALK mutation F1174L.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Smac mimetic LCL161 supports n ...... ells with ALK mutation F1174L.
@en
type
label
Smac mimetic LCL161 supports n ...... ells with ALK mutation F1174L.
@en
prefLabel
Smac mimetic LCL161 supports n ...... ells with ALK mutation F1174L.
@en
P2093
P2860
P356
P1433
P1476
Smac mimetic LCL161 supports n ...... ells with ALK mutation F1174L.
@en
P2093
Birgit Appl
Doerte Langemann
Georg Eschenburg
Konrad Reinshagen
Magdalena Trochimiuk
Patrick Hundsdoerfer
Safiullah Najem
P2860
P304
72634-72653
P356
10.18632/ONCOTARGET.12055
P407
P577
2016-09-15T00:00:00Z